Kerigo Ndirangu

<p>Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial</p>

Afisi Ismaila, Nancy Risebrough, Melanie Schroeder et al. · International Journal of COPD · 2019 · 36 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Systematic review and network meta-analysis of the efficacy and safety of tumour necrosis factor inhibitor–methotrexate combination therapy versus triple therapy in rheumatoid arthritis

Roy Fleischmann, Vanita Tongbram, Ronald van Vollenhoven et al. · RMD Open · 2017 · 29 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Efficacy and metabolic effects of lurasidone versus brexpiprazole in schizophrenia: a network meta-analysis

Daisy Ng‐Mak, Vanita Tongbram, Kerigo Ndirangu et al. · Journal of Comparative Effectiveness Research · 2018 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cost-effectiveness analysis of a single-inhaler triple therapy for patients with advanced chronic obstructive pulmonary disease (COPD) using the FULFIL trial: A UK perspective

Melanie Schroeder, Dhvani Shah, Nancy Risebrough et al. · Respiratory Medicine X · 2019 · 10 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17